Patents: New principles in preliminary injunction proceedings

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Patents: New principles in preliminary injunction proceedings

Sponsored by

maiwald-logo-cropped.PNG
justice-2060093.jpg

Heike Röder-Hitschke of Maiwald discusses a significant European Court of Justice (CJEU) ruling, and how it will affect future practice in preliminary injunction proceedings

On April 28 2022, the CJEU delivered its decision in the preliminary ruling case C-44/21 and held that the case law of the German Higher Regional Courts in proceedings for interim relief in patent matters is not compatible with Art. 9(1) of Directive 2004/48/EC (Enforcement Directive).

According to this case law, the grant of interim measures for infringement of a patent is in principle to be refused if the patent has not yet survived opposition or revocation proceedings in the first instance confirming its validity.

In our article of January 25 2021, we reported that the Munich Regional Court had turned to the CJEU with a corresponding request for a preliminary ruling (for said request and the discussion status, cf. GRUR 2021, 466 – Validity of a patent in preliminary injunction proceedings (with comment by Kühnen, presiding judge at the Dusseldorf Higher Regional Court, and the reply by Pichlmaier, judge at Munich Regional Court, in GRUR 2021, 557 – The significance of the grant of the patent for the prognosis of its validity in preliminary injunction proceedings).  In the underlying preliminary injunction proceedings, the court came to the conclusion that the applicant’s patent was legally valid and infringed, but saw itself prevented from issuing a preliminary injunction due to the above-mentioned binding case law of the Munich Higher Regional Court.

Specifics of the CJEU ruling

In its judgment, the CJEU emphasised that:

  • Granted patents are, in principle, presumed to be valid, and they enjoy, from the date of publication of the grant, the full protection afforded by Directive 2004/48, among other things;

  • Member states must ensure that, under Article 9(1), national courts have the power to order provisional measures and, after examining the particular circumstances of the case, to grant them;

  • Directive 2004/48 lays down a minimum standard and the remedies prescribed therein are intended to prevent, remedy, or put an end to any infringement of an existing intellectual property right.

The Court stated, with reference to the German case-law leading to the reference:

“Such case-law imposes a requirement which deprives Article 9(1)(a) of Directive 2004/48 of any practical effect in so far as it does not allow the national court to adopt, in accordance with that provision, an interlocutory injunction in order to terminate immediately the infringement of the patent in question even though that patent, according to the national court, is valid and is being infringed.” [paragraph 34]

“A national procedure aimed at the immediate termination of any infringement of an existing intellectual property right would be ineffective and, consequently, would disregard the objective of a high level of protection of intellectual property, if the application of that procedure were subject to a requirement such as that laid down by the national case-law referred to in paragraph 33 of the present judgment.” [paragraph 40]

Further, both Directive 2004/48 and the member states bound by it provided sufficient safeguards to prevent provisional measures and proceedings from being misused.

In the same decision, the CJEU also reiterated its views on the requirements for the implementation of the expedited procedure under Article 105 of the Rules of Procedure (see also Case C-590/20 of March 3 2022, with further references). The Munich Regional Court had requested that the case be dealt with on an expedited basis, as the nature of the case required a speedy decision.

The CJEU confirmed its previous case-law according to which the mere – albeit legitimate – interest of the applicant in having her rights clarified as quickly as possible in the context of preliminary injunction proceedings was not suitable to prove the existence of the exceptional circumstances required for Article 105.

A reference for a preliminary ruling in the context of domestic interlocutory proceedings is not in itself capable of establishing that the nature of the case requires its speedy disposal. The request was dismissed.

Consequences of the CJEU ruling

The German courts of first instance are now required, if necessary, to disregard the previous case law of the higher regional courts that is incompatible with Article 9(1) of the Enforcement Directive. The CJEU judgment contains an unambiguous instruction in this respect (paragraph 53) and a clear request to change established case law that is contrary to EU law (paragraph 52).

This highly anticipated ruling is likely to have a significant impact on future practice in preliminary injunction proceedings. It is true that courts have already developed and implemented extensive exceptions to the above-mentioned principle. However, the argument that a patent for an injunction has not yet survived proceedings on the validity of the patent in the first instance should no longer lead to the rejection of a request for interim injunction.

Rather, and more than ever, it will be up to the alleged infringer to make the doubtful validity of the patent credible and, on this basis, the courts will subject the respective patent to a thorough summary examination. It will be a challenge for all concerned to manage this with the speed that is customary for preliminary injunction proceedings in Germany.

more from across site and SHARED ros bottom lb

More from across our site

Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Aparna Watal, head of trademarks at Halfords IP, discusses why lawyers must take a stand when advising clients and how she balances work, motherhood and mentoring
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
The platform’s proactive intellectual property enforcement helps brands spot and kill fakes, so they can focus on growth. Managing IP learns more about the programme
Hire of José María del Valle Escalante to lead the firm’s operations in ‘dynamic’ Catalonia and Aragon regions follows last month’s appointment of a new chief information officer
Gift this article